Vertex Pharmaceuticals Inc / Ma - Net Worth and Insider Trading

Vertex Pharmaceuticals Inc / Ma Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vertex Pharmaceuticals Inc / Ma owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .

Click here to see the complete history of Vertex Pharmaceuticals Inc / Ma’s form 4 insider trades.

Insider Ownership Summary of Vertex Pharmaceuticals Inc / Ma

Ticker	Company	Transaction Date	Type of Owner
CRSP	CRISPR Therapeutics AG	2018-12-20	10 percent owner

Vertex Pharmaceuticals Inc / Ma Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vertex Pharmaceuticals Inc / Ma Ownership Network

Ownership Network List of Vertex Pharmaceuticals Inc / Ma

No Data

Ownership Network Relation of Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma Owned Company Details

What does CRISPR Therapeutics AG do?

Who are the key executives at CRISPR Therapeutics AG?

Vertex Pharmaceuticals Inc / Ma is the 10 percent owner of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Financial Officer Raju Prasad , Chief Business Officer Samarth Kulkarni , and General Counsel and Secretary James R. Kasinger .

CRISPR Therapeutics AG (CRSP) Insider Trades Summary

Over the past 18 months, Vertex Pharmaceuticals Inc / Ma made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 261,024 shares made by Samarth Kulkarni , a net sale of 25,642 shares made by James R. Kasinger , and a net sale of 3,932 shares made by .

In summary, during the past 3 months, insiders sold 44,610 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 44,610 shares. During the past 18 months, 306,882 shares of CRISPR Therapeutics AG (CRSP) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 299,882 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

CRISPR Therapeutics AG Insider Transactions

No Available Data

Vertex Pharmaceuticals Inc / Ma Mailing Address

Above is the net worth, insider trading, and ownership report for Vertex Pharmaceuticals Inc / Ma. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Vertex Pharmaceuticals Inc / Ma's mailing address is: Boston Ma 02210.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.